About Us
Bosnalijek is the largest industrial manufacturer of medicines in Bosnia and Herzegovina, established in 1951.
Our success is the result of deliberate strategy and joint efforts targeted at the company’s development.
Our success is the result of deliberate strategy and joint efforts targeted at the company’s development.
Press Centre
Bosnalijek is the largest industrial manufacturer of medicines in Bosnia and Herzegovina, established in 1951.
Our success is the result of deliberate strategy and joint efforts for the Company’s development.
Our success is the result of deliberate strategy and joint efforts for the Company’s development.
Portfolio
Products by generic name
Back
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
DIFEN, gastro-resistant tablet ..., 50 mg
International nonproprietary name : diclofenac sodium
Product category : Prescription medicines (Rx)
Strength : 50 mg
Pharmaceutical form : gastro-resistant tablets
Packaging : 20 tablets
Pharmacotherapeutic group :
M
MUSCULO-SKELETAL SYSTEM
M01
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
M01A
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS
M01AB
Acetic acid derivatives and related substances
M01AB05
Diclofenac
DIFEN, prolonged-release table ..., 100 mg
International nonproprietary name : diclofenac sodium
Product category : Prescription medicines (Rx)
Strength : 100 mg
Pharmaceutical form : prolonged-release tablets
Packaging : 20 tablets
Pharmacotherapeutic group :
M
MUSCULO-SKELETAL SYSTEM
M01
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
M01A
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS
M01AB
Acetic acid derivatives and related substances
M01AB05
Diclofenac
Q&A
If you have a question about any of our products, check whether it has already been answered in the Questions and Answers section.
TAKE A LOOK AT Q&A
If you are unable to find the answer under Q&A, then send your question and one of our medical or pharmaceutical experts will answer.
Newsletter
If you are a medical doctor or pharmacist, why not subscribe to our mailing list and receive the latest updates.
